期刊
VIRUSES-BASEL
卷 8, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/v8100296
关键词
carbohydrate binding agent; viral envelope glycoproteins; multivalency; resistance; immunogenicity; HIV; HSV; HCV
类别
资金
- NIH Intramural Research Program (National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK)
Griffithsin (GRFT), an algae-derived lectin, is one of the most potent viral entry inhibitors discovered to date. It is currently being developed as a microbicide with broad-spectrum activity against several enveloped viruses. GRFT can inhibit human immunodeficiency virus (HIV) infection at picomolar concentrations, surpassing the ability of most anti-HIV agents. The potential to inhibit other viruses as well as parasites has also been demonstrated. Griffithsin's antiviral activity stems from its ability to bind terminal mannoses present in high-mannose oligosaccharides and crosslink these glycans on the surface of the viral envelope glycoproteins. Here, we review structural and biochemical studies that established mode of action and facilitated construction of GRFT analogs, mechanisms that may lead to resistance, and in vitro and pre-clinical results that support the therapeutic potential of this lectin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据